New GPU engine in the on-device AI framework delivers comprehensive GPU and NPU support across Android, iOS, macOS, Windows, Linux, and web platforms. LiteRT, Google’s “modern” on-device inference ...

Advanced Micro Devices is rated a hold due to a lack of a competitive MOAT and lagging AI accelerator performance versus NVDA. AMD's revenue and earnings are expected to grow 20–30% YoY, but market ...

Abstract: “Active flux” is an alternative unitary concept for the control of practically all ac drives. As aligned to rotor d-axis (for synchronous and flux-modulation machines) and to rotor flux axis ...

Nvidia got the green light from President Donald Trump to sell its more advanced H200 AI chip to China. But there are questions over whether Beijing will want to buy them given its drive for ...

Bosch Advanced Ceramics is being acquired by the Sintokogio Group. The company, which has been supported by Bosch Business Innovations GmbH since 2016, specialises in the contact manufacturing of ...

Nvidia told investors back in August that its October-quarter revenue would hit $54 billion — a jaw-dropping 54% jump from last year. This isn't just acceleration; it's escape velocity. AMD, by ...

HOUSTON, Nov. 11, 2025 (GLOBE NEWSWIRE) -- March Biosciences (March Bio), a clinical stage biotechnology company developing cell therapies for hard-to-treat cancers, today announced that the U.S. Food ...

WASHINGTON, Nov 4 (Reuters) - The Trump administration is not planning to allow Nvidia (NVDA.O), opens new tab to sell its most advanced AI chip, known as the Blackwell, to China right now, the White ...

Trump wants Nvidia's advanced Blackwell chips for US companies only Nvidia has said it would supply Blackwell chips to South Korea Trump had hinted at scaled-down Blackwell chip sales to China in ...

For diehard duck hunters, any opportunity to improve downrange lethality is all but irresistible. After all, ducks can be tough, and premium pellet materials like tungsten and bismuth are only getting ...

Patients with previously untreated, locally advanced, unresectable or metastatic triple-negative breast cancer who are not candidates for inhibitors of programmed cell death protein 1 (PD-1) or ...